Insider Trading & Ownership - Dowden Nathan J

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Dowden Nathan J
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-06
Sale
2024-03-08
4:34 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
President & COO
1,826$12.32$22,499137,204
(Direct)
View
2023-09-06
Sale
2023-09-06
5:07 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
972$13.47$13,08969,668
(Direct)
View
2023-07-10
Sale
2023-07-12
4:33 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
7,097$18.03$127,93835,376
(Direct)
View
2023-06-20
Sale
2023-06-22
4:46 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
15,982$15.42$246,40342,473
(Direct)
View
2022-10-31
Sale
2022-11-02
4:54 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
2,100$24.05$50,49545,283
(Direct)
View
2022-10-25
Sale
2022-10-27
6:48 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
9,348$20.77$194,19147,383
(Direct)
View
2022-10-20
Sale
2022-10-24
5:13 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
6,080$18.66$113,42656,731
(Direct)
View
2022-09-26
Sale
2022-09-28
5:08 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
1,544$15.45$23,85462,811
(Direct)
View
2022-09-21
Sale
2022-09-23
4:55 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
4,293$15.11$64,87864,355
(Direct)
View
2022-09-15
Sale
2022-09-19
4:34 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
100$15.01$1,50168,648
(Direct)
View
2022-09-08
Sale
2022-09-12
4:14 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
1,777$15.11$26,84568,748
(Direct)
View
2022-06-27
Sale
2022-06-29
4:02 pm
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
7,714$13$100,28264,893
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-05
7:46 pm
N/A
2034-03-01
Entrada Therapeutics Inc.TRDADowden Nathan J
President & COO
143,200$0189,130
(Direct)
View
2024-03-04
Tax Withholding
2024-03-05
7:46 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
President & COO
343$12.42189,130
(Direct)
View
2024-03-04
Tax Withholding
2024-03-05
7:46 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
President & COO
409$13.37189,130
(Direct)
View
2024-03-05
Tax Withholding
2024-03-05
7:46 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
President & COO
1,486$12.28189,130
(Direct)
View
2023-09-01
Option Award
2023-09-06
5:07 pm
N/A
2033-09-01
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
35,700$069,668
(Direct)
View
2023-09-05
Tax Withholding
2023-09-06
5:07 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
436$14.4669,668
(Direct)
View
2023-03-01
Option Award(A)
2023-04-19
5:46 pm
N/A
2033-03-01
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
35,700$079,955
(Direct)
View
2023-03-01
Option Award
2023-03-03
4:33 pm
N/A
2033-03-01
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
71,400$0115,655
(Direct)
View
2023-03-02
Tax Withholding
2023-03-03
4:33 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
1,028$11.6115,655
(Direct)
View
2022-09-01
Option Award
2022-09-06
4:32 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
5,632$070,525
(Direct)
View
2022-07-01
Option Award
2022-07-06
4:18 pm
N/A
2032-07-01
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
33,788$033,788
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:11 pm
N/A
2032-03-01
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
78,838$0140,182
(Direct)
View
2021-10-28
Option Award
2021-11-01
6:58 pm
N/A
2031-10-28
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
95,148$095,148
(Direct)
View

Ownership
2021-10-28
8:58 pm
N/A
N/A
Entrada Therapeutics Inc.TRDADowden Nathan J
Chief Operating Officer
0$0279,411
(Direct)
View
(A) Indicate amendment filing.